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A B S T R A C T
Colorectal cancer is a worldwide disease with major clinical and economic impact, and its occurrence is de-
termined by a variety of factors. In addition to its hereditary component, it is also known to be associated with
various inflammatory processes, epigenetic alterations or modifications of the intestinal microbiota. The ali-
mentary habits are crucial in the conformation of gut microbiota. The Mediterranean diet is widely recognized
for its health benefits and has been associated with a lower risk of colon cancer. On the other hand, inflammation
is a process commonly associated with cancer, and the intestinal microbiota interacts with the host to maintain
normal function and health, particularly in processes of immunity and defense. Here, we are focusing in par-
ticular on two groups of substances (fibre, protein fractions) present in legumes whose mechanisms of action to
prevent colon cancer or inflammation are likely to be mediated by the intestinal microbiota functional com-
position.
1. Introduction
According to the Global Cancer Observatory (GCO) (IARC, WHO,
2018), which reports on the incidence, mortality and prevalence of the
main types of cancer for 184 countries of the world, colorectal cancer
(CRC) was the second most common type of cancer in women (sur-
passed only by breast cancer) and in men (only surpassed by lung
cancer) worldwide (Fig. 1A). In Mediterranean countries, values follow
a similar trend although with substantially lower values generally in-
cluding CRC (Fig. 1B). Prevalence values for CRC are second after
breast cancer and third after breast and prostate cancers worldwide and
in Mediterranean countries respectively (Fig. 1C & D). An increase in
CRC incidence rates for both males and females had been documented
from 1983–87 to 1998–2002 particularly in economically transitioning
countries including Eastern European countries, most parts of Asia, and
select countries of South America (Center, Jemal, & Ward, 2009). Given
the magnitude of the problem, the competent authorities have devel-
oped a series of guidelines to ensure efficient early detection of the
disease and appropriate monitoring of the people affected. The first
edition of the ‘European guidelines for quality assurance in CRC
screening and diagnosis’ was published in 2010 by the European
Commission (Arpaia & Rudensky, 2014). Likewise, several American
organizations came together to develop consensus guidelines for the
detection of adenomatous polyps and CRC (Levin, Lieberman,
McFarland, & Smith, 2008).
Scientific advances have made it possible to identify many of the
factors associated with the promotion of CRC and have helped to show
which of them can be modified to prevent the disease. In most cases,
there is no single factor which determines the development of CRC. The
age and male gender are important risk factors, but there are many
other and varied factors such as a family history (with a heritable
component of 35%, Lichtenstein, Holm, Verkasalo, & Iliadou, 2000),
the presence of Inflammatory Bowel Disease (IBD), infectious or po-
tentially infectious agents, and those associated with the diet like ex-
cessive alcohol consumption, high consumption of red and processed
meat, obesity, etc. (Brenner, Kloor, & Pox, 2014). Legume consumption,
the focus of the current review and one of the basic components of the
Mediterranean diet, has been linked with a decreased risk of suffering
10 major chronic diseases including CRC (Kromhout, Spaaij, & de
Goede, 2016; Song, Garrett, & Chan, 2015). In the current review, we
are paying special attention to two groups of substances (fibre, protein
fractions) present in legumes whose mechanisms of action to prevent
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CRC or inflammation are likely to be mediated by the intestinal mi-
crobiota (IM) functional composition.
2. Colorectal cancer (CRC) and inflammation
Inflammation is a process commonly associated with cancer as it
involves the interaction of various immune and inflammatory cells,
chemokines, cytokines and pro-inflammatory mediators which can lead
to signals directed to the proliferation of tumor cell growth and inva-
sion (Aggarwal, Shishodia, Sandur, Pandey, & Sethi, 2006; Aggarwal,
Sung, & Gupta, 2014; Korniluk, Koper, Kemona, & Dymicka-Piekarska,
2017). The cancer-inflammation connection has two pathways: an ex-
trinsic pathway, where inflammatory conditions facilitate the devel-
opment of cancer (by releasing chemicals, for example), and an intrinsic
pathway, where genetic alterations leading to cancer also stimulate the
inflammatory process, thus contributing to the establishment of a mi-
croenvironment favorable to tumor development. For this reason, re-
gardless of tumor origin, there are inflammatory cells in the vicinity of
all tumors (Vendramini-Costa & Carvalho, 2012). In particular, patients
with IBD (ulcerative colitis or Crohn's disease) have a higher risk of
developing CRC, and the risk is higher if the inflammation becomes
chronic (7 or more years). When chronic inflammation persists, an
environment in which immune surveillance mechanisms fail is created.
The inhibition of anti-tumor immune responses then leads to tumor
development (Fantini & Pallone, 2008; Rizzo, Pallone, Monteleone, &
Fantini, 2011). Other relevant factors are the extent and severity of
colon inflammation, the co-existence with primary sclerosing cho-
langitis (bile duct inflammation/scarring) or colon cells of abnormal
appearance (dysplasia), and family history (Mattar, Lough, Pishvaian, &
Charabaty, 2011; Terzić, Grivennikov, Karin, & Karin, 2010). Among
the many indications that confirm the link between inflammation and
CRC is the observation that various anti-inflammatory therapies reduce
or prevent CRC risk (Bastiaannet, Sampieri, Dekkers, & de Craen, 2012;
Crawford, 2014). In consequence, the ultimate molecular mechanisms
by which intestinal inflammation leads to cancer development are the
focus of intense research. The studies conducted so far suggest muta-
tions in tumor suppressor genes, induction of oxidative stress, nitric
oxide (NO), inhibition of DNA repair enzymes and production of clas-
togens as possible links (Mandal, 2018; Shastri, Vemuri, Gueven,
Shastri, & Eri, 2017; Vendramini-Costa & Carvalho, 2012). Non-ster-
oidal anti-inflammatory drugs (NSAIDs) are currently the main anti-
inflammatory agents with anti-tumorigenic properties, most likely due
to their inhibition of cyclooxygenase-2 (COX-2), which has been shown
to be of high activity in various types of tumors (Vendramini-Costa &
Carvalho, 2012).
3. The implication of the intestinal microbiota (IM) in CRC
In addition to a number of beneficial roles, gut bacteria have been
reported to be involved in various diseases, such as IBD, obesity, dia-
betes, carcinoma, HIV and autism (Sartor, 2008; Zhang, Li, Gan, &
Zhou, 2015). The human gastrointestinal tract (GIT) is home to over
100 trillion microorganisms, which together make up what is called the
IM. The size of this population far exceeds that of all other microbial
communities associated with the body’s surfaces, and was reported to
be about 10 times greater than the total number of our somatic and
germ cells (Bäckhed, Ley, Sonnenburg, Peterson, & Gordon, 2005), al-
though the number of intestinal bacteria has been recently revised to be
the same order as the number of human cells (Sender, Fuchs, & Milo,
2016). Microbial density reaches 104–107 cells per gram in the jejunum
and ileum and 1011 per gram in the colon (Walker, Duncan, Louis, &
Flint, 2014), and is dominated by five bacterial phyla (Firmicutes,
Bacteroidetes, Actinobacteria, Proteobacteria and Verrucomicrobia)
and one of archaea (Euryarchaeota). The IM interacts with the host to
maintain normal function and health of the GIT and the whole or-
ganism. It plays a role in the processes of immunity and defense,
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Fig. 1. Cancer incidence, mortality and prevalence values (number of cases per 100,000) worldwide (A,C) and in eight Mediterranean countries (Croatia, Cyprus,
France, Greece, Italy, Malta, Slovenia and Spain) (B,D).
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digestion and metabolism, inflammation and cell proliferation, and
communicates not only with the intestinal epithelium but also with
distant organs and body systems (Bajaj, Hylemon, & Younossi, 2012;
Nicholson, Holmes, & Wilson, 2005; Tillisch, 2014). In turn, the genetic
background of the host influences its microbiome functional composi-
tion (Knights, Lassen, & Xavier, 2013).
On the other hand, the microbiota inhabiting the GIT can be dif-
ferentiated into two major group: that closely associated with the mu-
cosa and that forming part of the intestinal content. This is relevant
because while mucosal microorganisms would be crucial for im-
munological priming, those mainly involved in nutrient digestion and
metabolic exchange with the host are more abundant in the lumen (Van
den Abbeele, Van de Wiele, Verstraete, & Possemiers, 2011). It has been
accordingly proposed that the intestinal lumen microbiota potentially
influences CRC risk via co-metabolism or metabolic exchange with the
host, while mucosa-associated microbiota potentially affects CRC risk
primarily through direct interaction with the host (Chen, Liu, Ling,
Tong, & Xiang, 2012). It is also known that mucosa-associated IM
composition differs from that in the feces (Eckburg, Bik, Bernstein, &
Purdom, 2005), which is likely to be closer in composition to that in the
lumen.
The IM is a rich source of molecules able to cause inflammation in
peripheral tissues of the body, such as lipopolysaccharide and pepti-
doglycan (Sartor, 2008). Lipopolysaccharide molecules bind to Toll-like
receptor 4 (TLR4) and to peptidoglycan type NOD receptors, which
activate pro-inflammatory signaling cascades (Tremaroli & Bäckhed,
2012). Toll-like receptors (TLRs) are proteins members of the pattern
recognition receptors (PRRs) family of the immune system (Dolasia,
Bisht, Pradhan, Udgata, & Mukhopadhyay, 2017). Their regulation in
the epithelial cells of the large intestine seems to be related to the
composition of the IM and the presence or not of pathogenic micro-
organisms, with increased expression of TLR2 and TLR5 in specific
pathogen-free mice (Lundin, Bok, Aronsson, & Björkholm, 2008).
Overexpression of TLR4 seems to be a critical factor in inflammation-
associated colorectal neoplasia through a mechanism associated with
increased production of COX-2 enzyme and the regulation of epidermal
growth factor receptor (EGFR) phosphorylation (Fukata, Chen,
Vamadevan, & Cohen, 2007; Fukata, Shang, Santaolalla, & Sotolongo,
2011). It has also been observed that REP sequences (remarkably
conserved extragenic palindromic nucleotide sequences) repeated
throughout the bacterial genome (Stern, Ames, Smith, Robinson, &
Higgins, 1984) from genomes of Gram-negative bacterial pathogens are
able to stimulate the Innate Immune System through the TLR9 receptor,
detecting a strong induction of production of IFN-α in splenocytes from
mice (Magnusson, Tobes, Sancho, & Pareja, 2007). Since it has been
described that REP sequences are species specific (Tobes & Ramos,
2005) and their distribution in the genome differs between strains of
the same species (Aranda-Olmedo, Tobes, Manzanera, Ramos, &
Marqués, 2002), different bacteria could be expected to interfere dif-
ferently in the immune response of the host. In general, all these results
suggest that the stimulation of the immune system caused by micro-
biota associated-inflammation could be regulated by regulating the
expression and/or the functionality of TLRs. As TLRs regulation is
linked to the IM composition, which in turn is mainly influenced by the
diet, TLRs activity, and consequently immunity/inflammation, may be
modulated by appropriate dietary interventions.
A recent review (Dahmus, Kotler, Kastenberg, & Kistler, 2018) has
examined the current research evaluating multiple proposed patho-
genic microorganisms including sulfidogenic bacteria such as Bilophila
wadsworthia, as well as Streptococcus bovis, Helicobacter pylori, Bacter-
oides fragilis, and Clostridium septicum. However, only a few micro-
organisms have been identified as carcinogens by the International
Agency for Research on Cancer (IARC) (Plummer, de Martel, Vignat, &
Ferlay, 2016). Within the GIT, some virulence factors stemming from
certain bacteria of the IM may be responsible for the initiation and
promotion of CRC by creating a pro-inflammatory environment that
favors the penetration of other species of bacteria in the epithelium
(Kostic, Chun, Robertson, & Glickman, 2013; Rubinstein, Wang, Liu, &
Hao, 2013). The intestinal tissue has thereby its barrier function im-
paired, facilitating the translocation of bacteria and the induction of
cytokines which maintain an inflammatory environment in the tumor
(Jobin, 2012). Intestinal bacteria thus regulate the inflammatory re-
sponse in the tumor microenvironment (Iida, Dzutsev, Stewart, &
Smith, 2013), and CRC may be caused by certain microbes that progress
within the inflammatory environment (Arthur, Perez-Chanonam,
Mühlbauer, & Tomkovich, 2012). In the opposite direction, the altered
host immune signaling could promote the extension of cancer pro-
moting bacteria in the IM in an inflammatory process.
Some specific cancers have been linked to bacterial or viral infection
(Selgrad & Muller-Schilling, 2018). As for CRC, it has not yet been re-
lated with any particular germ, but there is increasing evidence that the
IM is associated with the development and progression of CRC
(Irrazábal, Belcheva, Girardin, Martin, & Philpott, 2014; Marchesi,
Dutilh, Hall, & Peters, 2011) through the metabolites generated (Louis,
Hold, & Flint, 2014). A number of mechanisms have been proposed
(Nistal, Fernández-Fernández, Vivas, & Olcoz, 2015): (i) the induction
of chronic inflammation; (ii) genotoxins biosynthesis could act either
directly, by damaging DNA, or indirectly by interfering for example
with cell cycle regulation; and (iii) accumulation of toxic metabolites or
activation of certain dietary pro-carcinogenic components. A number of
examples of bacteria/bacterial groups for which some information ex-
ists on their implication in CRC are collected in Table 2.
Although the exact composition of the IM and its potential role in
the development and progression of CRC is still largely unknown, the
microbial structures of CRC patients and healthy individuals have been
shown to differ significantly (Gao, Guo, Gao, Zhu, & Qin, 2015; Pennisi,
2013). Even more, the mucosa-associated microbiota was found to
differ structurally between cancerous tissue and para-cancerous regions
(i.e., in “normal” mucosa of diseased individuals) (Chen et al., 2012).
As for particular groups, Gao et al. (2015) reported that Firmicutes and
Fusobacteria were over-represented whereas Proteobacteria was under-
represented in CRC patients. Also, Lactococcus and Fusobacterium ex-
hibited a relatively higher abundance while Pseudomonas and Escher-
ichia-Shigella were reduced in cancerous tissues compared to adjacent
non-cancerous tissues. However, Shen, Rawls, Randall, and Burcal
(2010) found higher bacterial diversity and richness in colonic polyps
when compared with control patients, with higher abundance of mu-
cosal Proteobacteria and lower abundance of Bacteroidetes. Therefore,
although CRCs have an increased enrichment of opportunistic patho-
gens and polymicrobial Gram-negative anaerobic bacteria, it is not yet
clear whether these opportunistic pathogens merely benefit from the
CRC microenvironment or influence disease progression. For the same
reason, the potential usefulness of pre- and probiotics to prevent CRC
remains controversial, since the number of clinical trials in humans
involving the use of probiotics for prevention or treatment of CRC is
scarce and study results obtained are very heterogeneous and not
consistent (Tsai et al., 2019). Nevertheless, in animal (rodent) studies a
clear reduction in aberrant crypt foci is mostly observed with prebiotic
and synbiotic preparations (probiotics plus prebiotics) even though the
effect of probiotics alone is not as clear (Azcárate-Peril, Sikes, & Bruno-
Bárcena, 2011). However, the rapid evolution of “omics” technologies
is beginning to provide the information needed to generate disease-
oriented, next generation probiotics able to modulate the IM by in-
troducing a carefully selected blend of beneficial organisms capable of
survival, persistence, and delivery of a wide range of bioactive com-
pounds.
The overall composition and diversity of the IM is probably relevant
in CRC development. Chen et al. (2012), by using pyrosequencing-
based analysis of the 16S-rRNA genes found that the overall microbial
structures of cancerous tissue and noncancerous tissue were similar;
however, the tumor microbiota exhibited lower diversity. The struc-
tures of the intestinal lumen microbiota and mucosa-adherent
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microbiota were also different in CRC patients compared to matched
microbiota in healthy individuals. Huipeng, Lifeng, Chuang, Jiaying,
and Yuankun (2014) found that the diversity and abundance of the IM
in the descending, transverse and ascending colon were more abundant
in healthy vs patients with CRC, with bacteria of the type Bacteroides as
predominant. Interestingly, these findings have also been found in pa-
tients and experimental animals with precancerous lesions (adenoma-
tous polyps) (Noor, Ridgway, Scovell, & Kemsley, 2010; Wei, Dong,
Wang, & Zhang, 2010). Sobhani, Tap, Roudot-Thoraval, and Roperch
(2011) found that the IM of patients with CRC had more Bacteroides/
Prevotella as compared with normal controls. Also, Mai, Maccrary,
Sinha, and Glei (2009) found a different IM composition between Na-
tive Americans and Afro-Americans, being Bacteroides spp more abun-
dant in the former. There are therefore a number of studies which focus
on the role of gender Bacteroides (B. fragilis, common and polymorphic
Bacteroides) in CRC (Chu, Esworthy, Chu, & Longmate, 2004; Hooper,
Wong, & Thelin, 2001; Moghimi-Dehkordi & Safaee, 2012).
4. Dietary habits that modulate factors associated with CRC
According to the World Cancer Research Fund (2007), all factors
taken into account, cancer is mostly a preventable disease, and cancers
of some sites, notably of the colon, are generally agreed to be greatly or
mostly affected by food and nutrition. On a global scale, it is estimated
that over 3 to 4 million cases of cancer can be prevented every year by
appropriate food and nutrition, regular physical activity, and avoidance
of obesity (Anand, Kunnumakkara, Sundaram, & Harikumar, 2008;
Wiseman, 2008). Many hypotheses have been developed to explain the
relationship between diet and CRC risk. These hypotheses tend to be
based on the concept of high-risk diets, which may either contain high
levels of carcinogens or lack one or more anticarcinogenic protective
factors (Sugimura, 2000).
However, the issue of the relationship between dietary components
and CRC risk is very complex and multifactorial. Diet plays a dominant
role in shaping the structure of the IM by influencing both its compo-
sition and functionality (Candela, Biagi, Maccaferri, Turroni, & Brigidi,
2012), and changes in the biodiversity and composition of the IM have
far-reaching consequences on the health and development of the host.
Cultural factors have a great influence in the type of diet consumed by a
population. Western diets are typically high in fat and animal protein,
while the Eastern diets are high in fiber. As a result, the IM appears with
different population profiles in individuals with different eating habits.
The impact of diet on the composition of the IM has been demonstrated
for example by comparative studies in children. Thus, African children
consuming a traditional rural diet (low in fat and animal protein and
rich in starch, fiber, and plant polysaccharides), showed a significant
enrichment in Bacteroidetes and a reduction in Firmicutes and En-
terobacteriaceae (Shigella spp and Escherichia spp) with respect to Eur-
opean children (De Filippo, Cavalieri, Di Paola, & Ramazzotti, 2010).
Also, Firmicutes were more represented and microbiota turned out to
be more diverse in Bangladeshi than in USA children (Lin, Bik, Costello,
& Dethlefsen, 2013).
The complex interactions between components of the diet and the
microbiome have further consequences on the immune function of the
host and on the origin and development of disease (Maslowski &
Mackay, 2011). In this context, further studies in different countries
with different dietary habits which influence the type and composition
of the IM are at present of utmost importance. A lot of attention has
been paid to dietary compounds able to modulate intestinal parameters
including those related with the IM. Dietary fibre is arguably the most
studied food component regarding the relationship between IM com-
position and gastrointestinal inflammatory processes
(Ananthakrishnan, Khalili, Konijeti, & Higuchi, 2013). One reason for
this is probably because it is broadly accepted that dietary re-
commendations to increase fibre consumption (up to at least 25 g/d for
adult women and 38 g/d for adult men) by increasing that of whole
grains, legumes, vegetables, fruits, and nuts should be broadly sup-
ported by food and nutrition practitioners (Dahl & Stewart, 2015).
Some other dietary compounds less studied so far in this context such as
Maillard reaction products (common components of processed foods,
frequent in the Western diet, and implicated in reduced protein di-
gestibility and other health conditions and diseases) (Aljahdali &
Carbonero, 2017) have been recently reported to modulate in vivo the
IM composition both in humans and in rats. Those effects, which were
found to be linked to the chemical structure and dietary amounts of the
different browning compounds, were related to changes in the pattern
of SCFA production and to decreased proportions of Lactobacillus spp.
and Bifidobacterium spp. counts, as well as increases in the Escherichia/
Shigella group numbers (Delgado-Andrade, Pastoriza de la Cueva,
Peinado, & Rufián-Henares, 2017; Seiquer, Rubio, Peinado, Delgado-
Andrade, & Navarro, 2014).
Among the epigenetic mechanisms which seem to play a role in
cancer development are changing patterns of DNA methylation, post-
translational modifications of histones, microRNAs and antisense RNAs,
and nucleosome positioning (Khare & Verma, 2012; Lao & Grady,
2011). Of these, DNA methylation (the enzymatic addition of a methyl
group at the 5-position of cytosine by DNA methyltransferases, DNMTs,
to produce 5-methylcytosine) is the epigenetic mechanism more widely
studied. Modifications of dietary nutrients can also affect DNA methy-
lation and regulate the homeostasis of the intestinal mucosa (Canani,
Costanzo, Leone, & Bedogni, 2011). Monozygotic twins have been
shown to be epigenetically indistinguishable during the early years of
life, but over time they exhibit notable differences which can be easily
attributable to the diet received (Fraga, Ballestar, Paz, & Ropero, 2005).
A significant impact of folate deficiency on DNA methylation has been
observed (Kim, 2005). In this way, foods that favor the increase of fo-
lates (legumes, green leafy vegetables, almonds, etc.) would thus favor
the re-methylation of certain genes in specific sites of their DNA. The
consumption of extra-virgin olive oil, which is rich in oleic acid, a ω9
monounsaturated fatty acid, has been associated with a lower risk of
colon cancer for decades (Reddy & Maeura, 1984). It has been recently
suggested that this property is due, at least in part, to its ability to up-
regulate the CB1 tumor suppressor gene through an epigenetic me-
chanism, both in vivo and in vitro (Di Francesco, Falconi, Di Germanio, &
Micioni Di Bonaventura, 2015). Curcumin, used as a spice in common
food, has been widely studied as a dietary chemopreventive agent for
CRC prevention, being designated as responsible for the methylation
changes of a set of genes (Link, Balaguer, Shen, & Lozano, 2013).
Although not all genes related to CRC and influenced by diet show
evidence of epigenetic modification (Van Breda, van Delft, Engels,
Kleinjans, & Mathers, 2009), experimental evidence indicates that some
dietary nutrients may have either a direct DNA methylation effect and/
or an indirect effect through IM modulation. For example, epigenetic
modifications induced by the lactic bacteria Lactobacillus acidophilus,
and ascribed to an increase in the expression of tumor suppressor genes,
have been reported (Lightfoot, Yang, Sahay, & Mohamadzadeh, 2013).
Evidence has also emerged that there is a relationship between epige-
netic changes and the development of resistance to chemotherapeutic
agents (Toyota, Suzuki, Yamashita, & Hirata, 2009). More importantly,
butyrate coming from the fermentation of some intestinal bacteria acts
as an inhibitor of histone deacetylase enzymes (HDACi). These enzymes
remove acetyl groups from histones, increasing their positive charge
and affinity for the DNA thus preventing transcription of genes by
condensation of the DNA structure. Butyrate, by inhibiting the action of
these enzymes, may increase the expression of tumor suppressor genes
(Berni Canani, Di Costanzo, & Leone, 2017).
5. CRC, Mediterranean diet and legume consumption
5.1. Epidemiology of CRC in connection with diet
As indicated above, it is important to underline here that unlike
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other cancers, such as lung cancer, no single risk factor accounts for
most cases of CRC. This is probably why some data suggest a weak
protective effect against CRC of diets rich in fruit, vegetables, cereal
fibre and whole grains, dairy products, or fish and, possibly, statin
therapy (Brenner et al., 2014). However, there is also information
suggesting that the higher prevalence of CRC in certain geographical
areas depends substantially on dietary factors. This seem to indicate
population studies of emigration of ethnic groups originating in areas of
low CRC prevalence (e.g. Asian immigrants to the U.S.) which have, in
successive generations, CRC prevalence indices similar to the auto-
chthonous population (Flood, Weiss, Cook, & Emerson, 2000;
Marchand, 1999).
The European countries bordering the Mediterranean Sea have been
characterized by consuming one of the dietary patterns recognized as
healthier, with an important consumption of legumes and with a re-
markable advantage in survival compared to the rest of the European
countries due to a lower incidence of cases of metabolic and cardio-
vascular syndrome, cancer, diabetes and neurodegenerative diseases
(Del Chierico, Vernocchi, Dallapiccola, & Putignani, 2014). The Medi-
terranean diet has been recently shown to affect the IM composition
(Garcia-Mantrana, Selma-Royo, Alcantara, & Collado, 2018). Thus, a
higher ratio of Firmicutes/Bacteroidetes was related with a lower ad-
herence to this diet, and a greater presence of Bacteroidetes was asso-
ciated with lower animal protein intake. High consumption of animal
protein, saturated fats, and sugars affected gut microbiota diversity. A
significantly higher presence of Christensenellaceae was found in in-
dividuals with higher adherence to the Mediterranean diet compared to
those with lower adherence. Higher bifidobacterial counts, and higher
total SCFA were related to greater consumption of plant-based nu-
trients, such as vegetable proteins and polysaccharides. Better ad-
herence to the Mediterranean diet was associated with significantly
higher levels of total SCFA. It has even been suggested that the follow-
up of a Mediterranean diet is associated with changes in the methyla-
tion pattern of certain genes related to the inflammation process and
that individuals following this type of diet have lower inflammatory
biomarkers (Arpón, Riezu-Boj, Milagro, & Marti, 2016). However, this
advantage has been gradually lost, most likely due in part to the pro-
gressive abandonment of their dietary traditions (Castelló, Amiano,
Fernández de Larrea, & Martín, 2018; Trichopoulos & Lagiou, 2004).
According to cancer forecasts, it is estimated that 194,680 new cases of
CRC (108,038 in men and 86,642 in women) will be diagnosed in the
Mediterranean countries by the year 2020 (Table 1).
In this context, as indicated above, legume consumption has been
related to a decreased risk of 10 major chronic diseases including CRC
(coronary heart disease, stroke, heart failure, diabetes, breast cancer,
colorectal cancer, lung cancer, chronic obstructive pulmonary disease,
dementia and depression) (Kromhout et al., 2016). Various meta-ana-
lysis have also concluded that legume consumption reduces the risk of
suffering CRC (Aune, Chan, Lau, & Vieira, 2011; Wang, Wang, Fu, Chen,
& Fang, 2013; Zhu, Sun, Qi, Zhong, & Miao, 2015). A number of epi-
demiological studies have highlighted the inverse relationship between
regular pulse consumption and risk of developing CRC, or even liver
cancer (Zhang, Xiang, Li, & Yang, 2013) or glioma (Benisi-Kohansal,
Shayanfar, Mohammad-Shirazi, & Tabibi, 2016), although other studies
did not find any effect of legume consumption on CRC incidence
(Vieira, Abar, Chan, & Vingeliene, 2017; World Cancer Research Fund/
American Institute for Cancer Research, 2007). Interestingly, although
CRC incidence data have increased worldwide, inverse tendencies be-
tween incidence of CRC and pulses consumption can be clearly ob-
served over the years (Fig. 2). Thus, in countries where pulse con-
sumption was maintained or has increased, such as for example USA
and Canada (Fig. 2C and D), CRC cases experienced a smaller increase
as compared with those geographical areas where the decrease in the
consumption of pulses was more pronounced. The latter is the case, for
example, of Japan (Fig. 2E), the countries of the European Union
(Fig. 2A) and, within these, the group of Mediterranean European
countries (Fig. 2B) where the consumption of pulses dropped by more
than 15% since the early 1960s to the early 1990s (Trichopoulos &
Lagiou, 2004) and continued with this decline in the following years
(Zander, Amjath-Babu, Preissel, & Reckling, 2016).
Adherence to the so-called Dietary Approaches to Stop
Hypertension (DASH), which include pulses as one of its main com-
ponents, has been associated with lower morbidity and mortality from
chronic diseases in both Western and Eastern populations (Benisi-
Kohansal et al., 2016; Yu, Zhang, Xiang, & Yang, 2014). Changes in
dietary habits are being repeatedly pointed as the main risk behavior
regarding CRC incidence. Thus, as an example the remarkable increase
in red and processed meats consumption as the source of proteins in-
stead of legumes during the second half of the 20th century in Spain has
been linked to increases in incidence, mortality and years of potential
life lost in both males and females due to CRC (Béjar, Gili, Ramírez,
López, & Cabanillas, 2010). It has recently been suggested that meat
intake influences the activation status of certain TLRs thus promoting
an inflammatory process [in which the nuclear transcription factor-κB
(NF-kB) intervenes] that leads to the development of CRC, whereas
fiber intake causes an opposite signal through TLR4 (with the secretion
of interleukin-10 and COX-2) that protects against CRC (Kopp, Vogel,
Tjonneland, & Andersen, 2018) (see above). In a 26-yr follow-up study
involving 2818 subjects, Tantamango, Knutsen, Beeson, Fraser, and
Sabate (2011) found that a higher frequency of consumption of cooked
green vegetables, legumes, dried fruit, and brown rice was associated
with a decreased risk of rectal/colon polyps, which are found in po-
pulations with high incidence of CRC. In particular, consuming legumes
at least 3 times/wk reduced the risk by 33%. Moreover, legume con-
sumption is also associated with lower risk of other epidemiologically
relevant pathologies such as diabetes, breast cancer, lung cancer and
chronic obstructive pulmonary disease (Kromhout et al., 2016). Thus,
in a recent large study involving 1868 participants (55–80 years-old),
Becerra-Tomás, Babion, Martínez-González, and Corella (2016) found
that the risk of metabolic syndrome was lower when one-serving/day of
processed red meat was replaced by legumes, poultry and rabbit, fish or
eggs. More specifically, a prospective study investigating the associa-
tion between total legumes consumption and grain legumes species (dry
beans, chickpeas, lentils, and fresh peas) with cancer and other-cause
mortality among elderly Mediterranean individuals found that higher
total legumes (27.34 g/day) and lentils (8.73 g/day) consumption was
associated with lower risk of cancer mortality (Papandreou, Becerra-
Tomás, Bulló, & Martínez-González, 2019).
5.2. Legume fibre and proteins as anti-carcinogens
Fibre. A number of anti-carcinogens have been reported in legumes:
dietary fibre, antioxidants, vitamins, trace minerals, phytate, phenolic
acids, lignans, and phytoestrogens, flavonoids and isoflavones (Aune
et al., 2011; Constantinou, Kiguchi, & Huberman, 1990). We will deal
here with two major components, i.e. dietary fibre and some protein
fractions, whose effect is closely related with IM functional
Table 1
Prediction of the incidence of CRC in the Mediterranean countries for the year
2020. Source: GLOBOCAN 2012, IARC.
Both sexes Male Female
194,680 108,038 86,642
ages < 65 ages >=
65
ages < 65 ages >=
65
ages < 65 ages >=
65
66,944 127,736 38,117 69,921 28,827 57,815
Countries included: Morocco, Algeria, Tunisia, Libya, Egypt, Israel, Lebanon,
State of Palestine, Syrian Arab Republic, Turkey, Greece, Albania, Montenegro,
Croatia, Bosnia Herzegovina, Slovenia, Italy, France (metropolitan), Spain,
Malta, Cyprus.
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composition. As already mentioned, dietary fibre is arguably the most
studied food component regarding the relationship between IM com-
position and gastrointestinal inflammatory processes. Changes in
dietary trends in industrialized societies revealing a decline in the
amount of consumed fiber are also associated with the emerging in-
crease of chronic non-transmissible diseases, such as obesity and asso-
ciated metabolic diseases, IBD, CRC, and allergies, among others
(Deehan, Duar, Armet, & Perez-Muñoz, 2017). However, it should be
also mentioned that human studies of fiber and CRC are somewhat
equivocal: fiber intake was not associated with CRC risk in 14 cohort
studies, whereas in 9 other cohorts an inverse association was detected
at least among some subgroups or for certain types of fiber (Song et al.,
2015). In a recent dose-response meta-analysis, Oh et al. (2019) re-
ported that although all fibre sources studied (cereals, vegetables,
fruits, legumes) were inversely associated with incident adenoma, the
evidence for CRC prevention is strongest for fibre from cereals and
grains (between 2 and 16 g/d). For vegetable and fruit fibres, data
suggested a non-linear relationship with CRC occurrence showing no
further reduction in risk beyond 5–7 g/d intake of vegetable or fruit
fibre. Similar results were also found by Aune et al. (2011). As for the
protective effects of dietary fibre against CRC, several plausible me-
chanisms have been hypothesized: stimulation of intestinal peristalsis
and reduction of transit time which leads to a decreased contact of
enterocytes with harmful substances, particularly carcinogens; promo-
tion of bacterial growth and SCFA production in the colon, which are
known to have a number of beneficial effects (see below); modulation
of faecal concentration, distribution and excretion of bile acids (puta-
tive risk factors for CRC), increased faecal bulk and lowered pH value
(Fechner, Fenske, & Jahreis, 2013).
Non-starch polysaccharides (NSP) and resistant starch are the main
components of dietary fibre. NSP behavior and activity within the GIT
is consequence of the fact that human intestinal enzymes cannot de-
grade complex carbohydrates or polysaccharides of plants, these non-
digestible carbohydrates (such as cellulose, xylan, pectin and inulin) are
metabolized by the colonic microbiota to oligosaccharides and mono-
saccharides, and then fermented giving as final products SCFA (mainly
acetate, propionate and butyrate), which are then absorbed in the
colon. Non-digestible starch (known as resistant starch) mainly present
in heat treated grains and tubers, is considered a significant part of the
dietary fibre fraction. Resistant starch has been reported to increase
SCFA production, as well as Ruminococcus spp (Ze, Ben David, Laverde-
Gomez, & Dassa, 2015) and Bifidobacterium spp numbers among other
bacterial groups (Portune, Benítez-Páez, Del Pulgar, Cerrudo, & Sanz,
2017), and therefore may be regarded as part of the preventive po-
tential of dietary fibre.
Butyrate is known to be important as an energy source for cellular
metabolism of the colonic enterocytes (Wong, de Souza, Kendall,
Emam, & Jenkins, 2006). Acetate and propionate reach the liver and
peripheral organs, where they are the substrate for gluconeogenesis and
lipogenesis. In addition to being sources of energy, fatty acids modulate
various processes in the GIT, such as absorption of electrolytes and
water, and have multiple effects on cells involved in inflammatory and
immune responses. Thus, SCFA modulate the production and release of
chemokines and the expression of cell adhesion molecules, affect the
migration of leukocytes, and induce apoptosis of lymphocytes, macro-












































































































































































































Fig. 2. CRC incidence vs. Pulses consumption. X axis: Year (1990–2013). Y axis (left): Incidence of CRC per 100,000 inhabitants. Y axis (right): consumption of pulses
(kg/capita/year). A: European Union. B: Mediterranean countries of the EU (includes Croatia, Cyprus, France, Greece, Italy, Malta, Slovenia and Spain). C: United
States of America. D: Canada. E: Japan. Sources: GHDx (GBD data), The World Bank (Population, total) and FAOSTAT.
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SCFA have been shown to affect the proliferation, differentiation and
modulation of gene expression in colonic epithelial cells of mammals
(Pool-Zobel, Selvaraju, Sauer, & Kautenburger, 2005). In particular,
butyrate and other SCFA have been reported to possess anti-in-
flammatory properties with an attenuation in the production of the
inflammatory cytokines TNF-α, IL-6 and IFN-γ (Arpaia & Rudensky,
2014; Goldsmith & Sartor, 2014). SCFA can directly enter the eu-
karyotic cells by diffusion, but they can also activate cells through cell-
surface receptors like G-protein-coupled receptors (GPRs) such as
GPR41 and GPR43. Several studies have demonstrated an anti-in-
flammatory role for the GPR43 receptor (Maslowski, Vieira, Ng, &
Kranich, 2009; Sina, Gavrilova, Förster, & Till, 2009). Thus, the GPR43
binding of SCFA may provide an example on the molecular links be-
tween diet, gastrointestinal bacteria metabolism, and immune and in-
flammatory responses.
High fibre diets are also usually associated to diets high in other
substances present in vegetable foodstuffs such as phytic acid. Myo-
inositol hexaphosphate or phytic acid is composed of an inositol sugar,
similar in structure to D-glucose, with six phosphate groups attached to
each hydroxy branch, and is ubiquitous in plants, particularly in cereals
and legumes (Shamsuddin, 1999). Phytic acid has been shown to pos-
sess anti-carcinogenic properties linked to a number of factors related
with its recognized ion binding properties, which result in antioxidant
and anti-proliferative activities (Steer & Gibson, 2002). However,
phytic acid may induce other beneficial effects by modulating the IM
activity and/or composition. Thus, it has been shown to improve the
composition of cecal organic acids, microbiota, and mucins, and it may
decrease the levels of serum pro-inflammatory cytokines in rats fed a
high-fat, mineral-sufficient diet (Okazaki & Katayama, 2014).
Proteins. Among the variety of food components of different che-
mical nature, special attention should be paid to the role that one of the
major dietary components, i.e. dietary proteins, may play on the IM
activity and/or composition. In general, high protein, reduced carbo-
hydrate diets alter the colonic microbiome, favoring a potentially pa-
thogenic and pro-inflammatory microbiota profile, decreased SCFA
production and increased ammonia, phenols and hydrogen sulphide
concentrations. These factors may have clinical importance as novel
therapeutic approaches to problems in which protein fermentation may
be implicated, such as malodorous flatus, IBD and prevention of CRC
(Portune et al., 2017; Yao, Muir, & Gibson, 2016). However, recent
reports (Aranda-Olmedo, Ruiz, Peinado, & Rubio, 2017; Utrilla,
Peinado, Ruiz, & Rodríguez-Nogales, 2015) link some legume protein
fractions, IM composition and prevention of intestinal inflammation.
Accordingly, we will focus here on some well-defined seed proteins
such as Bowman-Birk protease inhibitors (BBI), lectins and the albumin
fraction.
Bioactive compounds such as BBI are present in the albumin frac-
tion of legumes, are not altered by gastric acid or proteolytic enzymes
after their oral intake, and have been shown to reach the large intestine
in significant amounts in an active form (Clemente, Jimenez, Marín-
Manzano, & Rubio, 2008). Although traditionally regarded as anti-
nutrients, a growing body of evidence indicates that dietary BBI may
exert anti-inflammatory properties within the GIT when present in the
appropriate amounts (Clemente, Sonnante, & Domoney, 2011;
Clemente, Marín-Manzano, Jiménez, Arques, & Domoney, 2012;
Clemente & Arques, 2014; Lichtenstein, Deren, Katz, & Lewis, 2008).
Even more, protease inhibitors and BBI have been shown to be quite
resistant to thermal treatment (Olías et al., 2019) including extrusion in
some circumstances (Nikmaram et al., 2017). Therefore, even though
pulses are usually not consumed raw, significant amounts of active BBI
may remain in food after heat treatment and display a bioactive effect
within the GIT (Clemente et al., 2008; Clemente & Arques, 2014). The
anti-carcinogenic and anti-inflammatory properties of BBI have been
associated with their intrinsic ability to inhibit several serine proteases
involved in inflammatory processes, such as cathepsin G, elastase and
mast cell chymase (Clemente & Arques, 2014). BBI has also shown a
powerful inhibitory effect on the proliferation of two cancer cell lines
(gastric adenocarcinoma and colorectal adenocarcinoma), and in-
hibited Matrix Metalloproteinases implicated in cancer progression
(Fereidunian, Sadeghalvad, Oscoie, & Mostafaie, 2014). Pretreatment of
dextran sodium sulfate (DSS) treated mice with a pea (Pisum sativum)
seed protein extract (PSE) containing BBI ameliorated the colonic
mRNA expression of different pro-inflammatory markers (cytokines,
inducible enzymes, metalloproteinases, adhesion molecules, and TLRs),
as well as proteins involved in maintaining the epithelial barrier func-
tion (Utrilla et al., 2015). The effects found could however not be as-
cribed solely to the BBI content in the PSE (Aranda-Olmedo et al.,
2017).
Lectins are another group of proteins present in legume seeds that
have been related with cancer. Lectins are proteinaceous compounds
found in most plants, where they are implicated in plant defense
(Lannoo & Van Damme, 2014), and present usually in the form of
glycoproteins which have the ability to bind to certain carbohydrate
molecules without altering the covalent structure (Pusztai, Ewen,
Grant, & Peumans, 1990). For some time lectins have attracted the
attention of food scientists and nutritionists because some of these
proteins, such as soybean (Glycine max) and common bean (Phaseolus
vulgaris) lectins, are toxic to animals, and their toxicity is linked to their
capacity to bind to the intestinal mucosa (Pusztai, Grant, King, &
Clarke, 1990). Both proliferative and anti-proliferative non-toxic lectins
proposed in cancer therapy have been described (Pusztai, Bardocz, &
Ewen, 2008). However, the effect of toxic lectins within the intestine
has been shown to be partially linked to the modification by the lectin
of the antigenic structure of the intestinal mucosa, which increases the
capacity of E. coli to adhere to the intestinal wall through its own
bacterial lectins, and grow. The involvement of mucosa-adherent bac-
terial lectin/adhesins in the pathogenesis of Crohn’s disease and CRC
has also been demonstrated (Martin, Campbell, Hart, & Mpofu, 2004).
This would open the possibility to modify the intestinal mucosa by
using specific lectins to be more or less receptive to certain types of
bacteria. Thus, Pusztai, Grant, Spencer, and Duguid (1993) showed that
a non-toxic lectin (Galantus nivalis lectin) was able to prevent the E. coli
overgrowth found in rats fed Phaseolus vulgaris lectin, most likely due to
the blockage, by the G. nivalis lectin, of the anchoring sites of E. coli in
the digestive mucosa. More importantly, G. nivalis lectin given orally
significantly reduced the numbers of Salmonella typhimurium S986 in
the lower part of the small and large intestines of rats infected with this
pathogen and as a result also significantly improved rat growth
(Naughton, Grant, Bardocz, & Pusztai, 2000). The joint study of in-
testinal structure, microbial ecology and in vivo activity of lectins may
therefore open new interesting possibilities for the manipulation of the
digestive microbiota, with potentially relevant health implications
(Pusztai et al., 2008). Unlike BBI (see above), lectins have been re-
ported not to resist cooking under usual conditions (90–100 °C, 5min)
(He et al., 2017). Therefore, their potential interest is not linked to
consumption in normal eating behavior, but as functional tools to
modulate intestinal mucosa architecture and/or microbiota composi-
tion.
Albumins plus fibre extract. In the present context, the adscription
of shifts in microbiota composition and/or inflammation with one or
more defined seed chemical components would represent a significant
step forward. Although in vitro studies are abundant, not much in-
formation is found in the literature on in vivo studies involving isolated
or purified fibre fractions separated from other chemical components in
feed- or foodstuffs. Interestingly, blue lupin (Lupinus angustifolius)
kernel fibre improved colonic function and had beneficial effects on
putative risk factors for CRC such as faecal mass, transit time, SCFA,
faecal pH, and secondary bile acids concentrations in humans
(Nieuwdorp, Gilijamse, Pai, & Kaplan, 2014), and lowered E. coli counts
in rats (Rubio, Grant, Spencer, & Pusztai, 1995; Stern et al., 1984).
Accordingly, we decided to use a purified protein extract such as PSE in
our DSS mouse model. Unfortunately, with the information we have at
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present, it is not possible to establish the mode of action of the PSE
because the extract consisted of a soluble albumin extract containing
411.4mg protein/g freeze-dried material, the remaining consisting of
soluble NSP (Rubio, Pérez, Ruiz, & Guzmán, 2014; Utrilla et al., 2015).
As explained above, the albumin protein component, and particularly
BBI, might have and anti-inflammatory effect. But, on the other hand,
NSP fractions are known to be metabolized almost exclusively by the IM
giving place to SCFA (Flint, Scott, Duncan, Louis, & Forano, 2012).
Therefore, we suggested a combined effect of the protein fraction on the
inflammatory process itself with an effect on the microbiota probably
due mainly to the NSP fraction through SCFA production (Candela
et al., 2012; De Filippo et al., 2010).
PSE effects in vivo were studied in a DSS model of colitis (Aranda-
Olmedo et al., 2017; Utrilla et al., 2015). DSS treated animals are
commonly used as models for studying IBD (Valatas, Vakas, & Kolios,
2013) as changes in DSS treated rats are similar to those found in hu-
mans in the composition of the mucosa-associated and fecal microbiota
of patients with Crohn’s disease, ulcerative colitis, and pouchitis, i. e.
higher total counts of Escherichia/Shigella and Enterobacteriaceae to-
gether with reductions in Lactobacillus spp, Ruminococcus spp, Bacter-
oides spp and Bifidobacteria (Dicksved, Schreiber, Willing, & Petersson,
2012; Lupp, Robertson, Wickham, Sekirov, & Champion, 2007; Verma,
Verma, Kumari, Ranjha, & Paul, 2014). Most studies demonstrate a
decreased microbial diversity in active IBD, increased numbers of En-
terobacteriaceae, including E. coli, and decreased Firmicutes, with se-
lectively decreased Clostridium spp and F. prausnitzii. There are reports
of increased levels of the Bacteroidetes phylum members, although
reductions in Bacteroidetes have also been reported (Marchesi, Adams,
Fava, & Hermes, 2016; Sartor, 2008). A quite comprehensive study by
Frank, St Amand, Feldman, and Boedeker (2007) showed decreased
numbers of the phyla Firmicutes and Bacteroidetes with concomitant
increases in Proteobacteria and Actinobacteria in IBD. Given the pro-
blems associated with the different technical procedures used for mi-
crobial analysis, the high inter-individual variation in IM composition,
the usage of different animal models, etc., it is not surprising that
conflicting results are found in the literature on this particular issue.
Anyway, oral pre-treatment with PSE in DSS treated mice gave place to
a recovery of bacterial counts, partially or totally, to values in healthy
control mice in both colonic contents and tissue. Pyrosequencing ana-
lysis of the microbiota composition at the tissue level in the colon
confirmed the results obtained with real-time qPCR for both Lactoba-
cillaceae family and Lactobacillus spp proportions, which dropped in DSS
mice but were not different from controls in PSE pretreated animals
(Aranda-Olmedo et al., 2017).
Quite interestingly, Monk, Zhang, Wu, and Zarepoor (2015, Monk,
Lepp, Zhang, and Wu (2016)) recently found both an increase in Pre-
votellaceae and enhanced multiple concurrent gut health promoting
parameters that translated into reduced colitis severity in mice fed diets
supplemented with various raw Phaseolus vulgaris bean varieties in a
DSS model. Polyphenols were excluded, but the effect could not be
linked to any defined chemical fraction because only whole seed meals
were used in that study. Increased mRNA expression of antimicrobial
and barrier integrity promoting genes, and reduced proinflammatory
mediator expression genes, were also determined. In addition, bean
diets exerted a systemic anti-inflammatory effect during colitis by re-
ducing serum levels of IL-17A, IFNγ, TNFα, IL-1β and IL-6. Similar
results have been found with cooked Ph. vulgaris seed varieties (Zhang,
Monk, Lu, & Zarepoor, 2014)]. Therefore, a relationship between le-
gume consumption, microbiota modulation and lower inflammatory
markers is becoming increasingly evident.
6. Conclusions and prospects
CRC represents the second-third most common cancer in the wes-
tern world. Although in most cases there is no single factor which de-
termines the development of CRC, the IM is likely to have a direct and/
or indirect action on both development and treatment of CRC and other
chronic diseases. Accordingly, understanding the role of the diversity
and function of the IM in health and disease has become crucial to
design specific strategies to promote health, and to prevent and treat
diseases. The highest incidence/prevalence of CRC appears to depend
upon dietary factors, and although the Mediterranean countries have at
present a lower average incidence/prevalence (Fig. 1C & D), it is clearly
increasing, most likely due in part to the progressive rejection of the
Mediterranean diet, of which legumes have traditionally represented a
significant part. Although it has dropped over the last decades, legume
consumption has been associated with lower risk for suffering a number
of chronic diseases including CRC, and recent reports link legume
protein fractions, IM composition and prevention of intestinal in-
flammation, a process commonly associated with cancer. In fact, a re-
lationship between legume consumption, microbiota modulation and
lower inflammatory markers is becoming increasingly evident. Also,
experimental evidence indicates that some dietary components such as
legumes may have either a direct DNA methylation effect and/or an
indirect effect through IM modulation. In this context, the study of
immune receptors expression or activity is becoming increasingly re-
levant. TLRs are receptors of the immune system, whose regulation is
linked to the IM composition. As the latter is largely influenced by diet
composition, TLRs activity, and consequently immunity/inflammation,
may be modulated by appropriate dietary interventions. Therefore,
acording to the information currently available, there is the potential to
improve cancer treatment or prevention through well designed dietary
manipulations of the IM. However, the study of CRC-associated IM
should probably focus mainly on the mucosa-associated microbiota, as
the intestinal mucosa and stool are inhabited by distinctive microbial
communities, as also are tumor and normal mucosal samples. Samples
recovered from biopsies (v. g. rectal biopsies) may offer a closer insight
into host–microbes interactions that drive the pathophysiology of CRC.
Finally, in order to go ahead in the mechanistic approach, although
a substantial amount of information can be found in the literature on
the effects of different dietary approaches (high vs low fibre or carbo-
hydrate diets, high vs low fat diets, high vs low protein diets, etc.), we
are still lacking specific information on the effects of well-defined
chemical fractions or components in the very complex GIT environ-
ment. The main reason to pay more attention to this approach is that
the issue of the relationship between dietary components and CRC risk
is very complex and multifactorial, and no single risk factor accounts
for most cases of CRC. In this context, the adscription of shifts in mi-
crobiota composition and/or inflammation with one or more defined
seed chemical components would represent a significant step forward.
In this, fundamental research with animal models would represent a
good opportunity to study defined chemical components and to disclose
the mechanisms of pathogenesis, which would ease the devise of new
molecules or dietary manipulations. Last but not least, these dietary
manipulations may also have a strong impact on health expenditure by
reducing the economic cost of diagnosis and treatment of CRC.
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